RxDoctor Payments DataLook up a doctor →

Brent Ponce, MD

Orthopaedic Surgery · Charleston, SCNPI 1659358091

Payments from drug & device makers

$892,055in general payments, 2019–2025

Across 467 payments — averaging $1910.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$595K
  • Smith+Nephew$260K
  • Synthes GmbH$22K
  • CGG Medical Inc$4K
  • Prime Surgical, LLC$3K
  • Fidia Pharma USA Inc.$3K
  • plus $5K from 13 others
$26,635in research payments, 2019–2025

Across 6 payments — averaging $4439.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$22K
  • Integra Lifesciences Corporation$5K

What the payments were for

  • Royalty or licence$588,13567%
  • Consulting fees$216,71325%
  • Speaking & faculty fees$16,1712%
  • Travel & lodging$41,5255%
  • Food & beverage$8,9431%
  • Education$2,3510%
  • Gifts$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$892,055 in reported general payments places this provider in the 95th percentile of 325 orthopaedic surgery providers in South Carolina.

See all orthopaedic surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$165,468
Medicare patients
314
Services billed
3,952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam571$1,686
Methocarbamol141$1,116
Oxycodone Hcl163$890
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim62$460
Doxycycline Hyclate11$432
Gabapentin104$405
Mupirocin58$345
Ondansetron Hcl100$202
Diclofenac Sodium13$199
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$140
Tramadol Hcl31$97
Cephalexin12$51

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →